In this episode, Dr. Diane Reidy-Lagunes talks to pain management physician Dr. Neal Rakesh, and neurologist Dr. Anna DeForest, about the many options patients and doctors have to treat pain, including different therapies, safely managed painkillers, injections, and the possibility (and effectiveness) of psychedelics in the future.

In this episode, <a href="https://www.mskcc.org/cancer-care/doctors/diane-reidy-lagunes" aria-label="Link Dr. Diane Reidy-Lagunes">Dr. Diane Reidy-Lagunes</a> talks to pain management physician <a href="https://www.mskcc.org/cancer-care/doctors/neal-rakesh" aria-label="Link Dr. Neal Rakesh">Dr. Neal Rakesh</a>, and neurologist <a href="https://www.mskcc.org/cancer-care/doctors/anna-deforest" aria-label="Link Dr. Anna DeForest">Dr. Anna DeForest</a>, about the many options patients and doctors have to treat pain, including different therapies, safely managed painkillers, injections, and the possibility (and effectiveness) of psychedelics in the future.

How To Manage Chronic Pain During Cancer Treatment

Navigating the dating world after a cancer diagnosis can be tricky. From the fear of disclosing a diagnosis to insecurities around bodily changes, to the emotional baggage patients feel they’re bringing into a relationship, diving back into the dating pool comes with its challenges. In this episode, Dr. Diane Reidy-Lagunes sheds light on the universality of these fears with advice from MSK psychologist Talia Zaider and cancer survivor Irene Dimatulac. Through personal anecdotes and expert insights, they provide a nuanced look at the dating experience for cancer survivors and offer guidance for how to move forward with readiness and self-love.

Listen to our episode on Women’s Sexual Heath and Cancer.

Listen to our episode on Men’s Sexual Heath and Cancer.

Navigating the dating world after a cancer diagnosis can be tricky. From the fear of disclosing a diagnosis to insecurities around bodily changes, to the emotional baggage patients feel they’re bringing into a relationship, diving back into the dating pool comes with its challenges. In this episode, <a href="https://www.mskcc.org/cancer-care/doctors/diane-reidy-lagunes">Dr. Diane Reidy-Lagunes</a> sheds light on the universality of these fears with advice from MSK psychologist <a href="https://www.mskcc.org/cancer-care/doctors/talia-zaider">Talia Zaider</a> and cancer survivor <a href="https://www.mskcc.org/news/msk-s-adolescent-and-young-adult-program-supports-patients-throughout-their-treatment-journey">Irene Dimatulac</a>. Through personal anecdotes and expert insights, they provide a nuanced look at the dating experience for cancer survivors and offer guidance for how to move forward with readiness and self-love.
<a href="https://www.mskcc.org/videos/woman-guide-sex-and">Listen to our episode on Women’s Sexual Heath and Cancer.</a>
<a href="https://www.mskcc.org/videos/mans-guide-sex-and-cancer">Listen to our episode on Men’s Sexual Heath and Cancer.</a>

Dating After a Cancer Diagnosis

In this episode, Dr. Diane Reidy-Lagunes welcomes MSK exercise scientist Dr. Lee Jones back to the show to discuss the most recent findings about the effects of exercise on cancer prevention, treatment and recovery. Dr. Jones provides advice for patients to stay physically fit and battle fatigue, as well as the most effective training regimen for anybody, with or without cancer. 

In this episode, <a href="https://www.mskcc.org/cancer-care/doctors/diane-reidy-lagunes">Dr. Diane Reidy-Lagunes</a> welcomes MSK exercise scientist <a href="https://www.mskcc.org/research-areas/labs/lee-jones">Dr. Lee Jones</a> back to the show to discuss the most recent findings about the effects of exercise on cancer prevention, treatment and recovery. Dr. Jones provides advice for patients to stay physically fit and battle fatigue, as well as the most effective training regimen for anybody, with or without cancer.

How Exercise Can Help Treat and Prevent Cancer

While the holidays are meant to be a season of celebration, reflection and spending time with family and friends, it can also be a time of anxiety, grief or loneliness for those living with the reality of cancer. How does one find peace and meaning in the swarm of emotions that cancer brings up? In this episode, Dr. Diane Reidy-Lagunes and MSK chaplain Brian Kelly share their thoughts on what makes life meaningful and how to find your light in the darkest of times.

Listen to last year’s conversation with MSK psychologist Dr. Wendy Lichtenthal on gratitude and grief at the holidays.

While the holidays are meant to be a season of celebration, reflection and spending time with family and friends, it can also be a time of anxiety, grief or loneliness for those living with the reality of cancer. How does one find peace and meaning in the swarm of emotions that cancer brings up? In this episode, <a href="https://www.mskcc.org/cancer-care/doctors/diane-reidy-lagunes">Dr. Diane Reidy-Lagunes</a> and <a href="https://www.mskcc.org/experience/patient-support/counseling/spiritual-religious-care">MSK chaplain Brian Kelly</a> share their thoughts on what makes life meaningful and how to find your light in the darkest of times.
<a href="https://www.mskcc.org/videos/gratitude-grief-and-why-you-don-t-have-choose">Listen</a> to last year’s conversation with MSK psychologist Dr. Wendy Lichtenthal on gratitude and grief at the holidays.

What Makes Life Meaningful?

Spanish episode #3   |   Episodio #3 en español

Un reciente ensayo clínico para el cáncer de recto dirigido por Memorial Sloan Kettering ha captado la atención de médicos oncólogos y científicos del cáncer alrededor del mundo. Como un milagro, en un subconjunto de pacientes con la composición genética adecuada, una infusión intravenosa de inmunoterapia provocó una remisión completa. Los médicos se sorprendieron. El cáncer desapareció en todos los pacientes inscritos en el ensayo clínico. Los resultados son tan impresionantes que se publicaron en The New England Journal of Medicine y se presentaron en la reunión de oncólogos clínicos más grande del país en junio de 2022.

En este episodio, la Dra. Diane Reidy-Lagunes habla con los diseñadores de este estudio, los Dres. Andrea Cercek y Luis Diaz, sobre lo que significa esta noticia innovadora para los pacientes con cáncer y la comunidad científica en el futuro.

Más información sobre el Centro para el cáncer colorrectal y gastrointestinal de aparición temprana de MSK.


Breakthrough Rectal Cancer Drug Trial: What It Means For You

A recent clinical trial for rectal cancer headed up by Memorial Sloan Kettering has grabbed the attention of medical oncologists and cancer scientists around the world. Like a miracle, in a subset of patients with the right genetic makeup, an IV infusion of an immunotherapy caused a complete remission. The doctors were shocked. The cancer disappeared in every single patient enrolled on trial. The results are so impressive they were published in The New England Journal of Medicine and featured at the nation’s largest gathering of clinical oncologists in June 2022.

In this episode, Dr. Diane Reidy-Lagunes speaks with the designers of this study, Drs. Andrea Cercek and Luis Diaz, on what this groundbreaking news means for cancer patients and the scientific community moving forward.

Learn more about MSK’s Center for Young Onset Colorectal and Gastrointestinal Cancer

Spanish episode #3   |   Episodio #3 en español
Un reciente ensayo clínico para el <a href="https://www.mskcc.org/es/cancer-care/types/colorectal">cáncer de recto</a> dirigido por Memorial Sloan Kettering ha captado la atención de médicos oncólogos y científicos del cáncer alrededor del mundo. Como un milagro, en un subconjunto de pacientes con la composición genética adecuada, una infusión intravenosa de <a href="https://www.mskcc.org/es/cancer-care/diagnosis-treatment/cancer-treatments/immunotherapy">inmunoterapia</a> provocó una remisión completa. Los médicos se sorprendieron. El cáncer desapareció en todos los pacientes inscritos en el ensayo clínico. Los resultados son tan impresionantes que se publicaron en <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2201445">The New England Journal of Medicine</a> y se presentaron en la reunión de oncólogos clínicos más grande del país en junio de 2022.
En este episodio, la <a href="https://www.mskcc.org/cancer-care/doctors/diane-reidy-lagunes">Dra. Diane Reidy-Lagunes</a> habla con los diseñadores de este estudio, los Dres. <a href="https://www.mskcc.org/cancer-care/doctors/andrea-cercek">Andrea Cercek</a> y <a href="https://www.mskcc.org/cancer-care/doctors/luis-diaz-jr">Luis Diaz</a>, sobre lo que significa esta noticia innovadora para los pacientes con cáncer y la comunidad científica en el futuro.
Más información sobre <a href="https://www.mskcc.org/es/cancer-care/patient-education/adolescent-and-young-adult-aya-program-msk">el Centro para el cáncer colorrectal y gastrointestinal de aparición temprana de MSK</a>.
 Breakthrough Rectal Cancer Drug Trial: What It Means For You
A recent clinical trial for <a href="https://www.mskcc.org/cancer-care/types/rectal">rectal cancer</a> headed up by Memorial Sloan Kettering has grabbed the attention of medical oncologists and cancer scientists around the world. Like a miracle, in a subset of patients with the right genetic makeup, an IV infusion of an <a href="https://www.mskcc.org/cancer-care/diagnosis-treatment/cancer-treatments/immunotherapy">immunotherapy</a> caused a complete remission. The doctors were shocked. The cancer disappeared in every single patient enrolled on trial. The results are so impressive they were published in <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2201445">The New England Journal of Medicine</a> and featured at the nation’s largest gathering of clinical oncologists in June 2022.
In this episode, <a href="https://www.mskcc.org/cancer-care/doctors/diane-reidy-lagunes">Dr. Diane Reidy-Lagunes</a> speaks with the designers of this study, Drs. <a href="https://www.mskcc.org/cancer-care/doctors/andrea-cercek">Andrea Cercek</a> and <a href="https://www.mskcc.org/cancer-care/doctors/luis-diaz-jr">Luis Diaz</a>, on what this groundbreaking news means for cancer patients and the scientific community moving forward.
Learn more about <a href="https://www.mskcc.org/cancer-care/types/colorectal/colorectal-cancer-young-adults">MSK’s Center for Young Onset Colorectal and Gastrointestinal Cancer</a>

Ensayo innovador de medicamentos contra el cáncer de recto: lo que significa para usted

Recent research has shown that most, if not all, high grade serous ovarian cancers originate in the fallopian tubes. With no pronounced symptoms or tests to catch it early, ovarian cancer is usually detected in women with an average risk of cancer and in highly advanced stages. In this episode, gynecologic surgeons Kara Long-Roche (MSK) and Rebecca Stone (John Hopkins) join Dr. Diane Reidy-Lagunes to discuss a procedure that may be effective at preventing the most common form of ovarian cancer: a salpingectomy, or removal of the fallopian tubes. Because of the simplicity of this procedure, Drs. Long-Roche and Stone are advocating for salpingectomies to become routine in women who are seeking permanent birth control, and opportunistic at the time of other abdominal surgeries.

Recent research has shown that most, if not all, high grade serous <a href="https://www.mskcc.org/cancer-care/types/ovarian">ovarian cancers</a> originate in the fallopian tubes. With no pronounced symptoms or tests to catch it early, ovarian cancer is usually detected in women with an average risk of cancer and in highly advanced stages. In this episode, gynecologic surgeons <a href="https://www.mskcc.org/cancer-care/doctors/kara-long-roche">Kara Long-Roche</a> (MSK) and Rebecca Stone (John Hopkins) join <a href="https://www.mskcc.org/cancer-care/doctors/diane-reidy-lagunes">Dr. Diane Reidy-Lagunes</a> to discuss a procedure that may be effective at preventing the most common form of ovarian cancer: a salpingectomy, or removal of the fallopian tubes. Because of the simplicity of this procedure, Drs. Long-Roche and Stone are advocating for salpingectomies to become routine in women who are seeking permanent birth control, and opportunistic at the time of other abdominal surgeries.

Can We Prevent Ovarian Cancer?

Dr. Selwyn Vickers was named President and CEO of Memorial Sloan Kettering Cancer Center in September 2022. His vision of a future with equal access and better outcomes for all has inspired the faculty and staff at MSK. In this episode, Dr. Diane Reidy-Lagunes gets to know Dr. Vickers’ philosophy on achieving health equity, from restoring trust in the system, to overcoming racial bias in the clinic, to improving people’s access to top hospitals like MSK.

Subscribe to Cancer Straight Talk from MSK to be notified of new episodes.

<a href="https://www.mskcc.org/about/leadership/office-president/president-selwyn-vickers">Dr. Selwyn Vickers</a> was named President and CEO of Memorial Sloan Kettering Cancer Center in September 2022. His vision of a future with equal access and better outcomes for all has inspired the faculty and staff at MSK. In this episode, <a href="https://www.mskcc.org/cancer-care/doctors/diane-reidy-lagunes">Dr. Diane Reidy-Lagunes</a> gets to know Dr. Vickers’ philosophy on achieving health equity, from restoring trust in the system, to overcoming racial bias in the clinic, to improving people’s access to top hospitals like MSK.
Subscribe to Cancer Straight Talk from MSK to be notified of new episodes.

Achieving Excellent Healthcare for All: A Candid Conversation with MSK’s President & CEO, Dr. Selwyn Vickers

Mark Lewis was inspired to become a cancer doctor after living through the highs and lows of his father’s cancer journey. On day one of his oncology fellowship, Mark developed an abdominal pain and was suddenly diagnosed with the very same cancer that took his father; a cancer, he learned, that can be passed down to his children as well. In this episode, Dr. Diane Reidy-Lagunes chats with Dr. Mark Lewis, Director of Gastrointestinal Oncology at Intermountain Healthcare, about how his diagnosis has changed the way he practices medicine, and what every person should know about genetic testing and hereditary cancers.

Hear more from Dr. Mark Lewis on his weekly podcast, "Is It Serious?"

Make an appointment with MSK's Clinical Genetics Service here.

Mark Lewis was inspired to become a cancer doctor after living through the highs and lows of his father’s cancer journey. On day one of his oncology fellowship, Mark developed an abdominal pain and was suddenly diagnosed with the very same cancer that took his father; a cancer, he learned, that can be passed down to his children as well. In this episode, <a href="https://www.mskcc.org/cancer-care/doctors/diane-reidy-lagunes">Dr. Diane Reidy-Lagunes</a> chats with Dr. Mark Lewis, Director of Gastrointestinal Oncology at Intermountain Healthcare, about how his diagnosis has changed the way he practices medicine, and what every person should know about <a href="https://www.mskcc.org/cancer-care/risk-assessment-screening/genetic-counseling-and-testing">genetic testing</a> and <a href="https://www.mskcc.org/cancer-care/risk-assessment-screening/genetic-counseling-and-testing/hereditary-cancer-genes-and-hereditary-cancer-syndromes">hereditary cancers.</a>
Hear more from Dr. Mark Lewis on his weekly podcast, "Is It Serious?"
Make an appointment with MSK's Clinical Genetics Service <a href="https://www.mskcc.org/cancer-care/risk-assessment-screening/genetic-counseling-and-testing/making-appointment">here</a>.

When the Doctor Becomes the Patient: A Conversation with Dr. Mark Lewis

For nearly half of all breast cancer patients – those with low levels of the HER2 protein – targeted treatment options have always been limited. Palliative chemo has been the standard of care in stage 4 metastatic patients – until now. In this episode, Dr. Diane Reidy-Lagunes talks with Dr. Shanu Modi, the lead researcher of a groundbreaking MSK trial that proved a drug that combines an antibody with a chemotherapy – trastuzumab deruxtecan (T-DXd) – can control cancer cells and extend survival in stage 4 HER2-low breast cancer patients. With a fresh FDA approval, T-DXd is now being tested on other cancers and changing the way oncologists treat their patients.

For nearly half of all <a href="https://www.mskcc.org/cancer-care/types/breast">breast cancer</a> patients – those with low levels of the HER2 protein – targeted treatment options have always been limited. Palliative chemo has been the standard of care in stage 4 metastatic patients – until now. In this episode, <a href="https://www.mskcc.org/cancer-care/doctors/diane-reidy-lagunes">Dr. Diane Reidy-Lagunes</a> talks with <a href="https://www.mskcc.org/cancer-care/doctors/shanu-modi">Dr. Shanu Modi</a>, the lead researcher of a <a href="https://www.mskcc.org/news-releases/asco-2022-practice-changing-findings-identify-her2-low-targetable-subset-breast-cancer-redefining-treatment-more-60-percent-her2-negative-metastatic-breast-cancer-patients">groundbreaking MSK trial</a> that proved a drug that combines an antibody with a chemotherapy – trastuzumab deruxtecan (<a href="https://www.mskcc.org/cancer-care/patient-education/fam-trastuzumab-deruxtecan">T-DXd</a>) – can control cancer cells and extend survival in stage 4 HER2-low breast cancer patients. With a fresh FDA approval, T-DXd is now being tested on other cancers and changing the way oncologists treat their patients.

A Game-Changing Cancer Drug Gives Stage 4 Breast Cancer Patients New Hope

Spanish episode #2   |   Episodio #2 en español

Somos lo que comemos, y no hay duda de que ciertos estilos de vida aumentan el riesgo de padecer cáncer. Entonces, ¿cómo nos ayuda la comida a reducir ese riesgo? ¿Dónde puedo obtener ayuda para encontrar alimentos saludables? ¿Y qué debo comer si tengo cáncer? Médica oncóloga Diane Reidy-Lagunes habla con sus colegas de MSK, la nutricionista Karla Giboyeaux y la gastroenteróloga Delia Calo, sobre cómo formar buenos hábitos en nuestra vida diaria para reducir el riesgo de cáncer — incluso qué comprar y cocinar y la programación de exámenes regulares para la detección de cáncer.

Programa tu examen de detección de cáncer aquí.

Obtén más información sobre el Centro Ralph Lauren aquí.

Suscríbete para recibir más episodios de Cancer Straight Talk from MSK en español.


Lowering Your Cancer Risk with a Healthy Diet

We are what we eat, and there’s no doubt that certain lifestyles increase the risk of developing cancer. So how does food help us reduce that risk? Where can I get help finding healthy food? And what should I be eating if I have cancer? In this episode, medical oncologist Diane Reidy-Lagunes talks with her MSK colleagues, nutritionist Karla Giboyeaux and gastroenterologist Delia Calo, about building good habits in our daily lives to reduce the risk of cancer — from grocery shopping and cooking to scheduling regular screenings.

Schedule your cancer screening here.

Learn more about the Ralph Lauren Center here.

Subscribe to receive more episodes of Cancer Straight Talk from MSK in Spanish.

Spanish episode #2   |   Episodio #2 en español
Somos lo que comemos, y no hay duda de que ciertos estilos de vida aumentan el riesgo de padecer cáncer. Entonces, ¿cómo nos ayuda la comida a reducir ese riesgo? ¿Dónde puedo obtener ayuda para encontrar alimentos saludables? ¿Y qué debo comer si tengo cáncer? Médica oncóloga Diane Reidy-Lagunes habla con sus colegas de MSK, la nutricionista Karla Giboyeaux y la gastroenteróloga Delia Calo, sobre cómo formar buenos hábitos en nuestra vida diaria para reducir el riesgo de cáncer — incluso qué comprar y cocinar y la programación de exámenes regulares para la detección de cáncer.
<a href="https://www.mskcc.org/es/appointments/request-appointment?appointment_type=new" data-stringify-link="https://www.mskcc.org/es/appointments/request-appointment?appointment_type=new" data-sk="tooltip_parent">Programa tu examen de detección de cáncer aquí.</a>
<a href="https://www.mskcc.org/es/locations/directory/ralph-lauren-center-cancer-care/cancer-screening-ralph-lauren" data-stringify-link="https://www.mskcc.org/es/locations/directory/ralph-lauren-center-cancer-care/cancer-screening-ralph-lauren" data-sk="tooltip_parent">Obtén más información sobre el Centro Ralph Lauren aquí.</a>
Suscríbete para recibir más episodios de <a href="https://www.mskcc.org/cancerstraighttalk">Cancer Straight Talk from MSK</a> en español.
 Lowering Your Cancer Risk with a Healthy Diet
We are what we eat, and there’s no doubt that certain lifestyles increase the risk of developing cancer. So how does food help us reduce that risk? Where can I get help finding healthy food? And what should I be eating if I have cancer? In this episode, medical oncologist Diane Reidy-Lagunes talks with her MSK colleagues, nutritionist Karla Giboyeaux and gastroenterologist Delia Calo, about building good habits in our daily lives to reduce the risk of cancer — from grocery shopping and cooking to scheduling regular screenings.
<a href="https://www.mskcc.org/appointments/request-appointment?appointment_type=new" data-stringify-link="https://www.mskcc.org/es/appointments/request-appointment?appointment_type=new" data-sk="tooltip_parent" data-remove-tab-index="true">Schedule your cancer screening here.</a>
<a href="https://www.mskcc.org/locations/directory/ralph-lauren-center-cancer-care/cancer-screening-ralph-lauren" data-stringify-link="https://www.mskcc.org/es/locations/directory/ralph-lauren-center-cancer-care/cancer-screening-ralph-lauren" data-sk="tooltip_parent" data-remove-tab-index="true">Learn more about the Ralph Lauren Center here.</a>
Subscribe to receive more episodes of <a href="https://www.mskcc.org/cancerstraighttalk">Cancer Straight Talk from MSK</a> in Spanish.

Reducir el riesgo de cáncer con una dieta saludable

"Cancer Straight Talk from MSK" brings together national experts and cancer patients to have straightforward, evidence-based conversations. Our mission is to educate and empower patients and their families to make the right decisions and live happier, healthier lives.

"Cancer Straight Talk from MSK" brings together national experts and cancer patients to have straightforward, evidence-based conversations. Our mission is to educate and empower patients and their families to make the right decisions and live happier, healthier lives.

Cancer Straight Talk from MSK

Cancer Straight Talk from MSK brings together national experts and cancer patients to have straightforward, evidence-based conversations. Our mission is to educate and empower patients and their families to make the right decisions and live happier, healthier lives.

Cancer Straight Talk from MSK brings together national experts and cancer patients to have straightforward, evidence-based conversations. Our mission is to educate and empower patients and their families to make the right decisions and live happier, healthier lives.

Cancer Straight Talk

Social links:

Follow the podcast:

37 clip(s)